Theme: Recent advancements and therapeutic techniques in the field of gastroenterology

Gastro 2016

Renowned Speakers

Gastro 2016

Track 1: Gastrointestinal Carcinogenesis and Therapeutics

Gastrointestinal Carcinogenesis is the second common most diagnosed cancer diagnosed globally both in both women and men. Colorectal cancer is effecting highly in recent past in newly diagnosed GI cancers. Pancreatic ductal adenocarcinoma tops the list of the most fatal cancer due to lack of early diagnosis and limited success of systemic therapeutics. This is the mean reason behind the increased research activities towards development of novel therapeutics and remarkable progress has been made in this aspect of science and medicine.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 2: Inflammatory Bowel Disease Research vs Treatment / Management

Treatment of Inflammatory Bowel Disease Research includes the care of a patient with inflammatory bowel disease which can be either medical or surgical in nature or a combination of both. One of the major goal of this therapy is the achievement of absolution and the prevention of disease flares maintenance.

In Crohn’s disease, the concept of deep mucosal healing is becoming highly promoted. There are several studies which involves the use of anti-TNF agents and other immune modifiers; which results in the elimination of inflammation.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 3: Gastrointestinal Bleeding- Treatment and Management 

Acute upper gastrointestinal bleeding is the most prevalent gastroenterological emergency and has a substantial mortality & morbidity. Management strategies of the gastroenterological diseases have transmuted dramatically over recent decades due to the exordium of acid suppressive therapy histamine-2 receptor antagonists and especially due to use of endoscopic therapy & proton pump inhibitors.

Major symptoms of Gastrointestinal Bleeding are as melena, hematochezia, hematemesis or progressive anemiapy. Immediate evaluation and appropriate treatment is of major importance in these patients.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 4: Pancreatic Diseases and Treatment

The role of pancreas is to synthesize and secretion of insulin and glucon. Major pancreatic diseases are inflammation of the pancreas. Pancreatic disease may be caused due to infections, chronic alcohol use, medications, trauma,   gallstones, tumours, and genetic abnormalities. Symptoms often include features like astringent and constant fever over several days, and may be accompanied by regurgitating, nausea, tachycardia and abdominal swelling gressive anemiapy. Diagnosis of Pancreatitis is preliminary done by physical examination and by checking the levels of amylase and lipase enzymes in the blood.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 5: Emerging Therapies for Viral Hepatitis and Liver Fibrosis

New techniques to prevent and diagnose viral hepatitis C virus (HCV) are evolving exponentially. With the prelude of interferon‐α monotherapy predicated on triple therapies with pegylated interferon‐α and ribavirin, it increases the percentage of curing patients infected with HCV genotype-1 upto approximately 70%.

Cirrhosis is the end stage of Liver fibrosis which occurs due to series of actions to achieve injurious processes. Doubtlessly, liver fibrosis and cirrhosis are the most common disease globally.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 6: Treatment for Functional GI Disorders

Functional Gastrointestinal diseases remain a prevalent quandary in the pediatric age group. These conditions were firstly diagnosed in 1958 when a group of children with recurrent or sedulously assiduous abdominal pain that interfered with functional daily living.

This review mainly focused on cognitive behavioral, pharmacologic, dietary & complementary medical treatment. Irritable bowel syndrome is most common in adults.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 7: Gastrointestinal Pharmacotherapy

Gastrointestinal Pharmacotherapy for the gastroenterological and gastrointestinal disorders, such as dyspepsia & irritable bowel syndrome are complex with multiple reason affecting to their pathophysiology. As the result it has drafted significant challenges to the pharmaceutical industry when endeavouring to develop incipient and efficacious drugs. This provides a brief prelude to the difficulties and how the pharmaceutical industry is remoulding its drug developmental blueprints.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 8: Gastrointestinal Radiology

Gastrointestinal Radiology or GI Radiology uses a form of real-time x-ray called fluoroscopy and a barium-based contrast material to produce images of the stomach, oesophagus, small intestine & large and other parts of digestive system.  It is secure, non-invasive, and may be habituated to avail accurately acid reflux, diagnose pain, blood in the stool & other symptoms.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 9: Gastrointestinal Therapeutic Endoscopy- Advancements and Challenges

Recent advancement in gastrointestinal & gastroenterological therapeutic endoscopic technology, with emphasis on imaging & treatment of disorders of the oesophagus, small & large intestine has elongate our erudition regarding the endoscopic diagnosis of gastro-oesophageal reflux disease with the avail of endoscopic therapy and suggest incipient potential applications for biliary endoscopy.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 10: Use of NSAID’s and Antibiotic Therapy

The utilization of antibiotic therapy perpetuates to increment as a result of accumulations of evidence of aid in both primary & secondary treatment strategies for gastrointestinal disease and in gastrointestinal complications such as bleeding & ulceration. These jeopardies may be further promoted by the the use of other adjunctive medications, such as corticosteroids, anticoagulants & NSAID’s. Only with these construal medicos can congruously and plenary evaluate the jeopardy profile for individual patient and either by altering the medications or initiate prophylactic therapy in an endeavour to reduce gastrointestinal complications.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 11: Clinical Nutrition in Gastrointestinal Diseases

Victuals assimilation is the major function of the gastrointestinal tract. Many gastrointestinal diseases have paramount alimental effects. The target will be on the aspect of the liver in regulating the supply of carbohydrate & lipid fuels as well as ascertaining the scope of essential substrates to peripheral tissues. The clinical features of malnutrition & its concrete effects on the gastrointestinal tract and liver will be discussed with the diet therapy in gastrointestinal disease. Conclusively, a way to clinical pabulum will be presented, including alimental assessment and the rational utilization of enteral and parenteral alimental support.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 12: Traditional and Herbal Medications

Traditional medicine is the sum total of the cognizance, skills, and practices predicated on the theories, credence’s, & experiences whether explicable or not, utilized in the maintenance of health as well as in the obviation, diagnosis, amelioration or treatment of physical and phrenic illness.

Herbal medications include herbal preparations, herbal materials, herbs & culminated herbal products, which contain as active ingredients components of plants, or other plant materials, or cumulations.

Therapeutic activity refers to the prosperous obviation, diagnosis & treatment of physical and phrenic illnesses, amelioration of symptoms of illnesses, as well as benign alteration or regulation of the physical and phrenic status of the body.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 13: Gastroenterology - animals models and future perspectives

Every ‘scientific discovery’ commences with a hypothesis and trials, which is the critical step in composing a well-designed study. As consequential as it is to ask the correct questions to compose the hypothesis, it is equipollent consequential to be cognizant of the available implements to derive the answers.

Experimental models provide a crucial platform on which to tissues, interrogate cells, & even whole animals. There are majorly two paramount purposes: investigation of biological mechanisms to understand diseases & the opportunity to perform preclinical tribulations of incipient therapies.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 14: Probiotics as Gastrointestinal Therapeutics

Probiotics are being utilized with incrementing frequency as a treatment for several medical conditions such as allergic diseases, bacterial diseases, renal diseases & renal cancer as well as urinary tract infections, & aversion of dental caries/respiratory infections. Probiotics are utilized as a treatment for a variety of gastrointestinal disorders. In this review, proposed mechanisms of action, formulations & distribution systems, safety, and concrete GI disorders for which probiotics have been used are discussed.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 15: Recent Advancements and Current research in Gastrointestinal Therapeutics

The current industry update, with information sourced from gastrointestinal therapeutics and Gastroenterological companies regulatory & patent agencies as well as the current research on scientific literature. Although this section being dedicated to recent development in ‘man-made’ drug research it is eminent.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 16: Hepatocellular Carcinoma (Liver Cancer)

Hepatocellular carcinoma corresponds to majority of liver cancers. Only cancers that start in the liver are called liver cancer.  Hepatitis (B or C) are the main reason of Hepatocellular carcinoma. Treatment options for HCC are based on various factors but especially on staging & tumour size. In most cases, the cause of liver cancer is scarring of the liver (cirrhosis).

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Track 17: Orthotopic Liver/Pancreastransplant

An Orthotopic Liver transplant is an operation that supersedes a patient's diseased liver with a whole or partial liver from a donar. People who generally need liver transplants typically have one of the following conditions:

1) Acute Liver/Pancreas Failure.

2) Chronic Liver/Pancreas Failure.

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and AssociatesTrack 18: Gastric Bypass Surgery- Types and Treatment
To test the feasibility of methods to conduct a more immensely colossal multisite tribulation to understand the perdurable reaction of gastric bypass surgery complications, Roux-en-Y gastric bypass surgery compared with an intensive diabetes medical, Intensive Treatment program for Type 2​diabetes & weight management test the feasibility of

Related Gastro Conferences | Gastroenterology Conferences | Conference Series LLC3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA. American Gastroenterological Association, The American Society for Gastrointestinal Endoscopy (ASGE), World Gastroenterology Organisation, Society of American Gastrointestinal and Endoscopic Surgeons, European Society of Gastroenterology and Endoscopy Nurses and Associates

Conference Series LLC, the World Class Open Access Publisher and Scientific Event Organizer is delighted to host “6th Global Gastroenterologists Meeting” during August 11-12, 2016 at Birmingham, UK. This gastrointestinal conference highlights the theme “Recent advancements and therapeutic techniques in the field of gastroenterology”. For more details please visit conference series.

Conference Series LLC organizes 300+ International Conferences every year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. 

Gastro 2016 mainly focuses on the latest diagnostic and therapeutic techniques for gastric diseases. This gastro conference discusses the latest research outcomes and technological advancements in the field and brings together leading gastroenterologists, surgeons, physicians, research scholars, students along with industrial and pharma professionals to exchange share their views on critical aspects of gastroenterology research. This gastroenterology conference brings together Presidents and Eminent Personalities to explore opportunities on emerging platforms in the field of gastrointestinal therapeutics. With members from around the world focused on learning about latest diagnostic and treatment procedures of various gastrointestinal diseases and all the related aspects of gastrointestinal diseases this is your best opportunity to reach the largest assemblage of participants from the entire world. From the workshop and speech in this gastroenterology conference from the eminent people of gastroenterology, you can update your knowledge about current situation of gastroenterology and receive name and recognition at this 2-day event. Gastro conference will help to provide platform to share ideas. World-renowned speakers with their ultimate talks on the most recent techniques, tactics, and the avant garde technologies in gastrointestinal therapeutics are the hallmarks of this gastroenterology conference

Gastrointestinal Carcinogenesis and Therapeutics

Gastrointestinal   Carcinogenesis as a group are the second most common cancers diagnosed in both men and women. Of all the GI cancers, colorectal cancer is the most common one amongst newly diagnosed GI cancers and pancreatic ductal adenocarcinoma is the most fatal one due to lack of early diagnosis and limited success of systemic therapeutics increased research activities towards development of novel therapeutics. Remarkable progress has been made in pathogenesis, biology, and molecular genetics of Gastric surgery.

Gastro cancer is managed by therapeutics with multi-disciplinary approach, involving several medical, surgical, radiological, pathological, gastroenterologists, hepatologists, and scientists. Key innovations and novel therapies have led to improved understanding of pathogenesis and achieve earlier detection, and advances in the management of Gastric banding and gastroplasty surgery. The most prevalent of gastrointestinal cancers is colorectal cancer in the Western world and gastric cancer in the Eastern world. Colorectal cancer is the third most common cancer in the world, with nearly 1.4 million new cases diagnosed in 2012 and Gastric cancer accounts for approximately 9,52,000 deaths each year worldwide. There are about 900 medical universities working on gastrointestinal cancers worldwide. This gastroenterology conference will provide a common place to be together and share their gastroenterology researches.

Inflammatory bowel disease Research vs Treatment / Management

The care of a patient with inflammatory bowel disease Research can be either medical or surgical in nature or, in many patients, a combination of both the treatment and Management of IBDR. The goals of therapy are the achievement of remission and the prevention of disease flares maintenance.

The concept of deep mucosal healing, particularly in Crohn’s disease, is becoming increasingly advocated. There are several studies, primarily involving anti-TNF agents and occasionally immune modifiers; that have shown that the elimination of inflammation as demonstrated by endoscopic and histologic criteria results in a decrease in the rate of surgery, the use of corticosteroids, and the rate of hospitalization.

The medical approach for patients with symptomatic care and mucosal healing following a stepwise approach to medication, with escalation of the medical regimen until a response is achieved.

Aminosalicylates, Antibiotics, Corticosteroids, Immunomodulators, PharmacotherapyTumor necrosis factor inhibitors Monoclonal antibodies, UC is surgically curable. Crohn's disease and ulcerative colitis are the principal types of inflammatory bowel disease. In the United States, it is currently estimated that about 1-1.3 million people suffer from IBD. According to the Crohn's & Colitis Foundation of America, about 1.4 million Americans have Crohn’s disease or gastric ulcer. Of those, about 700,000 have Crohn’s. Gastro conference has a special eye to deal with Crohn’s disease.

Gastrointestinal Bleeding- Treatment and Management

Acute upper gastrointestinal bleeding is the most common gastroenterological emergency and has a considerable morbidity and mortality. Management strategies have changed dramatically over recent decades due to the introduction of acid suppressive therapy histamine-2 receptor antagonists and especially proton pump inhibitors and endoscopic therapy.

Patients with Gastrointestinal Bleeding can present with various symptoms such as hematemesis, hematochezia, melena, or progressive anemia. Immediate evaluation and appropriate treatment is of major importance in these patients. Laparoscopic gastric surgery is generally safe in the setting of gastrointestinal bleeding, as long as the patient has been sufficiently resuscitated before the procedure. Treatment and Management with scopy examinations summarized only one endoscopic complication perforation of a diverticulum was reported. A nasogastric tube can be used to administer this solution if the patient is unable to tolerate it by mouth. Those patients who have bled and apparently stopped, it is reasonable to administer the prep and perform the examination on an elective or semi elective basis. For those patients with continued hematochezia, the examination should be performed as soon as possible. GI bleeding results in 250,000 to 300,000 hospitalizations and 15,000 to 30,000 deaths per year in the United States. More than $2.5 billion is spent annually for inpatient care of this problem. 

Pancreatic diseases and Treatment

Pancreatic diseases are inflammation of the pancreas it also synthesizes and secretes insulin and glucon. Pancreatic or pancreatitis disease may be caused by gallstones, chronic alcohol use, trauma, medications, infections, tumors, and genetic abnormalities that is often severe and constant over several days, and may be accompanied by fever, nausea, vomiting, tachycardia and abdominal swelling.

Treatment for Pancreatitis is diagnosed preliminarily by physical exam and the levels of amylase and lipase in the blood. Other tests it may be done to detect gallstones or to identify the damaged pancreas and other blood tests may need to be done.

Gallstones may be removed using therapeutic endoscopic retrograde cholangiopancreatography (ERCP). This year, an estimated 48,960 adults (24,840 men and 24,120 women) in the United States will be diagnosed with pancreatic cancer. It is estimated that 40,560 deaths (20,710 men and 19,850 women) from this disease will occur this year. Pancreatic cancer is the eighth most common cancer in women and the fourth leading cause of cancer death in men and women.

Emerging therapies for Viral Hepatitis and Liver Fibrosis

Emerging therapies to treat viral hepatitis C virus (HCV) are evolving rapidly. With  the introduction of interferon‐α monotherapy based on triple therapies with pegylated interferon‐α and ribavirin , the chances of curing patients infected with HCV genotype 1 have improved from <10% to approximately 70%. 

Liver fibrosis occurs as a result of a wide range of injurious processes and in its end-stage results in cirrhosis. Indeed, liver fibrosis and cirrhosis represent a major worldwide healthcare burden. Recent progress in liver transplantation, the management of portal hypertension and the treatment of chronic viral hepatitis have had an important impact.

However, these approaches are not without their limitations – in particular, issues regarding organ availability for transplantation and serve to highlight the urgent requirement to influence pharmacologically the underlying fibrotic process in many patients. Gastro conference will be having a special session on Viral Hepatitis.

Treatment for Functional GI disorders

Functional Gastrointestinal  disorders remain a common problem in the pediatric age group, with pediatric gastro oncology. These conditions were first recognized  in 1958 when he coined the earlier term ‘recurrent abdominal pain’ (RAP) for a group of children with recurrent or persistent abdominal pain that interfered with functional daily living and had no evident organic etiology.

This review focuses on dietary, pharmacologic, cognitive behavioral and complementary medical treatment. IBS is most common in adults along with gastroenteritis and most of the treatments in the adult population have been geared toward treating that disorder.

Medications used to treat depression, anxiety, and seizures have become increasingly attractive agents for use in Functional Gastro Intestinal Disorders because they act upon the central and peripheral nervous system to modulate mood, visceral, and neuropathic pain, as well as autonomic function, in part, through anticholinergic effects.

Antidepressants such as tricyclic antidepressants (TCAs), serotonin reuptake inhibitors (SSRIs), and monoamine uptake inhibitors improve symptoms of IBS in adults. Antidepressants act by decreasing pain perception, improving mood and disturbed sleep patterns, and perhaps regulating motility. Of all the functional GI disorders, irritable bowel syndrome (IBS) is the most studied and among the most common. IBS is highly prevalent, affecting between 10–15% of the U.S. population. A Significant proportion – 35% to 40% of individuals who report IBS in the community are male and 60% to 65% of individuals who report IBS in the community are female.

Gastrointestinal Pharmacotherapy

Gastrointestinal Pharmacotherapy for functional gastrointestinal disorders, such as irritable bowel syndrome and functional dyspepsia, are complex conditions with multiple factors contributing to their pathophysiology. As a consequence and have posed significant challenges to the pharmaceutical industry when trying to develop new and effective treatments.

This review provides an overview of these difficulties and how the industry is reshaping its drug developmental strategies. It describes some of the more significant and encouraging advances that have occurred, and discusses how future research might embrace the opportunities provided by advances in genetic and in particular, epigenetic research.

Gastrointestinal Therapeutic Endoscopy- Advancements and Challenges

Advances in gastrointestinal Therapeutic endoscopic technology, with emphasis on imaging and treatment of disorders of the esophagus and small intestine and extend our knowledge regarding the endoscopic diagnosis of gastroesophageal reflux disease with the aid of endoscopic therapy and suggest new potential applications for biliary endoscopy.

Despite initial great enthusiasm for these procedures, the lack of well-done, controlled, prospective studies with clear endpoints and adequate follow-up has limited the current role for these modalities in our therapeutic arsenal against gastroesophageal reflux disease with advancements and challenges. In 2009, the U.S. market for GI endoscopic devices was valued at over $1.6 billion. This is an increase of nearly 5 percent from 2008. Nearly 23 million procedures were performed with GI endoscopic devices in 2009. More than 60 percent of these were colonoscopies. Virtual colonoscopies decreased by more than 7 percent in 2009 from 2008, but are expected to show notable growth over the next five years. 

Gastric Bypass Surgery- Types and Treatment

To test the feasibility of methods to conduct a larger multisite trial to determine the long-term effect of  gastric bypass surgery complications, Roux-en-Y gastric bypass  surgery compared with an intensive diabetes medical and weight management -Weight Achievement and Intensive Treatment  program for Type 2​ diabetes.

Use of NSAID’s and Antibiotic Therapy

The use of antibiotic therapy continues to increase as a result of accumulations of evidence of benefits in both primary and secondary treatment strategies for gastrointestinal disease. Gastrointestinal complications such as ulceration and related bleeding. These risks may be further compounded by the ancillary use of other adjunctive medications, such as nonsteroidal anti-inflammatory drugs (NSAID’s), corticosteroids, and anticoagulants. Given is the high prevalence of antiplatelet therapy in clinical practice, coupled with an increase emphasis on their extended use, especially after implantation of a drug-eluting stent, it is imperative that physicians know the potential benefits and the associated risks of antiplatelet therapy for primary or secondary prevention of cardiac ischemic events when combined with NSAID agents. Only with this understanding can physicians appropriately and fully evaluate the risk profile for each patient and either change medications or initiate prophylactic therapy in an attempt to reduce gastrointestinal complications.

Clinical Nutrition in Gastrointestinal Diseases

Food assimilation is the major function of the gastrointestinal tract. Many gastrointestinal diseases have important nutritional effects. Digestion and absorption of nutrients are discussed elsewhere. The focus will be on the role of the liver in regulating the supply of carbohydrate and lipid fuels as well as ensuring the availability of essential substrates to peripheral tissues. The clinical features of malnutrition and specific effects of malnutrition on the gastrointestinal tract and liver will be discussed along with diet therapy in gastrointestinal disease. Finally, an approach to clinical nutrition will be presented, including nutritional assessment and the rational use of enteral and parenteral nutritional support.

Traditional and Herbal Medications

Traditional medicine is the sum total of the knowledge, skills, and practices based on the theories, beliefs, and experiences indigenous to different cultures, whether explicable or not, used in the maintenance of health as well as in the prevention, diagnosis, improvement or treatment of physical and mental illness.

Herbal medications include herbs, herbal materials, herbal preparations and finished herbal products, which contain as active ingredients parts of plants, or other plant materials, or combinations.

Therapeutic activity refers to the successful prevention, diagnosis and treatment of physical and mental illnesses; improvement of symptoms of illnesses; as well as beneficial alteration or regulation of the physical and mental status of the body.

Probiotics as Gastrointestinal therapeutics

Probiotics are being used with increasing frequency as a treatment for several medical conditions, such as allergic diseases bacterial, renal diseases and renal cancer and urinary tract infections, and prevention of dental caries or respiratory infections. Probiotics are used as a treatment for a variety of gastrointestinal disorders. In this review, the historical perspectives, proposed mechanisms of action, formulations and delivery systems, safety, and specific GI disorders for which probiotics have been used are discussed.

Recent Advancements and Current research in Gastrointestinal Therapeutics

The present industry update, with information sourced from Gastrointestinal therapeutics companies regulatory and patent agencies as well as the current research on scientific literature. Despite this section being dedicated to recent advancements in ‘man-made’ drug research it is notable.

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

 

 

 

 

Summary

Gastro 2016 highlights the theme “Recent advancements and therapeutic techniques in the field of gastroenterology”. It mainly focuses on the latest diagnostic and therapeutic techniques for gastric diseases. It discusses the latest research outcomes and technological advancements in the field and brings together leading gastroenterologists, surgeons, physicians, research scholars, students along with industrial and pharma professionals to exchange share their views on critical aspects of gastroenterology research. There have been increases in the incidence of most gastrointestinal disorders in Europe which have major implications for future healthcare provision. Gastrointestinal cancer is the leading cause of cancer death in Europe. Recent studies of market value of GI therapeutics for major diseases in the eight major markets is expected to decrease in value from $6.8 billion in 2012 to $6.6 billion by 2019 forecasts business intelligence provider GBI Research. The major factors currently stabilizing the market include the increasing prevalence of GI diseases, growing awareness of the importance of detecting these diseases early and the availability of effective diagnostics creates an urgent need for organizing this gastroenterologists conference.

For more details please visit- http://gastro.conferenceseries.com/

Scope & Importance:

Gastro 2016 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results about all aspects of gastro diseases. This gastro conference also provides the chance for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of Gastrointestinal therapeutics. It helps in promoting the advancement of gastroenterology. This gastro conferences provides a platform for organizations, companies, associations, societies, institutions, statutory bodies and other authorities and individuals interested in the causes, diagnosis, prevention and treatment of gastrointestinal diseases.

Gastroenterology is a specialty that tends to receive relatively little attention from a policy perspective and compared with other specialties, attracts relatively little charitable research funding. There have been increases in the incidence of most gastrointestinal disorders in Europe which have major implications for future healthcare provision. Gastrointestinal cancer is the leading cause of cancer death in Europe. It is also the most common cancer in men and the second most common in women after breast cancer. "Bariatric surgery conferences" is a general need for further research into the incidence, prognosis and public health burden of many gastrointestinal disorders across Europe and a particular need for more studies from Eastern Europe, along with pan-European and multinational studies.

Why Birmingham?

Birmingham was also one of the founding cities for the Euro cities group and is also sitting as chair. It is considered to be a Beta-global city, rated as the third most globally influential city in the UK after London and Manchester. Birmingham is home to one of the largest shopping centers in the UK, the Bullring. It is also the busiest in the UK, attracting 36.5 million visitors in its first year. Birmingham is the most visited retail destination outside London and the retail sector makes up a large proportion of the city's economy.

Conference Highlights:

·Gastrointestinal Carcinogenesis and Therapeutics

·Inflammatory Bowel Disease Treatment and Management

·Gastrointestinal Bleeding- Treatment and Management

·Colorectal diseases and treatment

·Emerging therapies for Liver diseases

·Treatment for Functional GI disorders

·Gastrointestinal Pharmacotherapy

·Gastrointestinal Therapeutic Endoscopy- Advancements and Challenges

·Gastric Bypass Surgery- Types and Treatment

·Use of NSAID’s and Antibiotic Therapy

·Clinical Nutrition for Gastrointestinal Diseases

·Traditional and Herbal Medications

·Probiotics as Gastrointestinal therapeutics

·Recent Advancements and Current research in Gastrointestinal Therapeutics

Why to attend???

With members from around the world focused on learning about latest diagnostic and treatment procedures of various gastrointestinal diseases and all the related aspects of gastrointestinal diseases this is your best opportunity to reach the largest assemblage of participants from the entire world. From the workshop and speech of the eminent people of gastro conferences 2016, you can update your knowledge about current situation of gastroenterology and receive name and recognition at this 3-day event. World-renowned speakers with their ultimate talks on the most recent techniques, tactics, and the avant garde technologies in gastrointestinal therapeutics are the hallmarks of this gastro conference 2016.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://gastro.conferenceseries.com/sponsors.php

Target Audience:

The target audience include Gastroenterologists, General practitioners, Pediatricians, Internal medicine specialists, Surgeons and participants from all leading universities, clinical research institutions and diagnostic service provider companies.

·Hospitals 30%

·Academia/Research60%

·Others 10%

Major Gastroenterology Associations around the Globe

·American Gastroenterological Association

·United European Gastroenterology

·Canadian Association of Gastroenterology (CAG)

·European Association for Gastroenterology, Endoscopy and Nutrition

·The Japanese Gastroenterological Association (JGA)

·IGA - Israel Gastroenterology Association

·Association of Gastroenterologists of Bosnia nad Herzegovina

·Bulgarian Association of Surgeons and Gastroenterologists

·European Crohns and Colitis Organisation

·Gastroenterohepatology Association of Montenegro - GAM

·The Australian and New Zealand Gastric and Oesophageal Surgery Association (ANZGOSA)

·Asian Pacific Association of Gastroenterology (APAGE)

·Ukrainian Association of Endoscopy

 

Major Gastroenterology Societies around the Globe

·Gastroenterological Society of Australia

·British society of Gastroenterology

·European Society of Gastrointestinal Endoscopy (ESGE)

·European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN)

·European society of Neuogastroenterology & Motility

·American Society for Gastrointestinal Endoscopy

·British society for Pediatric Gastroenterology, Hepatology and Nutrition

·North American society for Pediatric Gastroenterology, Hepatology and Nutrition

·Russian Society for Digestive Endoscopy

·Japanese Society of Gastroenterology

·Hong Kong Society of Gastroenterology 

·Hong Kong Society of Digestive Endoscopy

·Emirates Gastroenterology & Hepatology Society 

·Belgian Society of Gastroinestinal Endoscopy

·Cyprus Society of Gastroenterology

·Czech Gastroenterological Society

·Danish Society of Gastroenterology and Hepatology

·Korean Society of Gastroenterology

·Ohio Gastroenterology Society

Industries associated

Top Universities in UK:

·Birmingham City University

·University of Aston

·University of Birmingham

·Newman University, Birmingham

Major Universities around globe

•University of Oxford                                      

•University of Cambridge                               

•Harvard University                                       

•University of California, Berkeley (UCB)    

•Yale University                                                

•Princeton University                                      

•Stanford University                                        

•Columbia University                                       

•National University of Singapore (NUS)    

•UCL (University College London)                  

•University of Chicago                                      

•University of Toronto                                     

•Peking University

Universities associated

 

Global Market value of gastrointestinal therapeutics

Recent studies of market value of gastrointestinal therapeutics shows differences in different parts of the world. In 2012, the value of the gastrointestinal therapeutics market in major developed countries amounted to an estimated $6.8 billion. This total is forecast to decline at a Compound Annual Growth Rate (CAGR) of 0.3% between 2012 and 2019. The value of the IBS market amounted to an estimated $727m, and is forecast to increase at a CAGR of 14.4% between 2012 and 2019. The value of the UC market amounted to an estimated $2.2 billion in 2012, and is expected to increase at a CAGR of 6% during the forecast period. The value of the CD market amounted to an estimated $3.8 billion, which is expected to decline at a CAGR of 7.5% between 2012 and 2019.

 

Funding for Gastrointestinal therapeutics

 

Physician statistics

Health-care systems vary among countries and we were interested in how this might impact on gastroenterology manpower. The number of gastroenterologists in Canada and compared this with four countries where data were available over the Internet in either French or English. The number of gastroenterologists per 100,000 of the population was 3.9 in the United States, 3.48 in France, 2.1 in Australia, 1.83 in Canada, and 1.41 in the U.K. This variation in number of gastroenterologists was not reflected in the overall number of specialists per 100,000, which was similar in all five countries. Furthermore, the difference in gastroenterology manpower did not correlate with the amount of gross domestic product spent on health care. Countries with a low number of gastroenterologists per 100,000 all had a strong primary-care gatekeeper system, although this observation may be coincidental, as only five countries were studied. Canada had the most equitable distribution of gastroenterologists across the country with only modest differences among provinces. The United States had the most variation in the number of gastroenterologists per 100,000 of the population among states.

 

References:

1. http://www.marketresearch.com/product/sample-8026525.pdf

2. http://www.marketresearchreports.com/

3. http://www.medgadget.com/

4. http://www.prnewswire.com/

5. http://www.transparencymarketresearch.com/

6. http://www.businesswire.com/

7. https://www.cag-acg.org

 

Gastro-2015

Conference Series LLC  hosted International Conference and Exhibition on Gastrointestinal Therapeutics scheduled during August 25-27, 2015 in Valencia, Spain with the theme, “Advanced Therapeutic Options and Treatment Procedures for Gastrointestinal Disorders".

The conference had multiple sessions including Keynote Presentations, Panel Discussions and Poster Sessions. We received active participation from various scientists, researchers, students and leaders from the field of Gastrointestinal Therapeutics who made this event successful.

Various sessions were carried out with enlightening presentations from speakers all around the world focusing on the below mentioned scientific tracks:

· Inflammatory Bowel Disease Research vs. Treatment/Management  
· Treatment for Functional GI disorders
· Gastrointestinal Carcinogenesis and Therapeutics      
· Gastrointestinal Bleeding- Treatment and Management           
· Gastrointestinal Therapeutic Endoscopy- Advancements and Challenges        
· Emerging Therapies for Viral Hepatitis and Liver Fibrosis        
· Recent Advancements and Current Research in Gastrointestinal Therapeutics            
· Probiotics as Gastrointestinal Therapeutics     
· Clinical Nutrition in Gastrointestinal Diseases
· Gastric Bypass Surgery- Types and Treatment           
· Pancreatic Diseases and Treatment        
· Traditional and Herbal Medications       
· Use of NSAID’s and Antibiotic Therapy          
· Gastrointestinal Pharmacotherapy

The conference was initiated with a series of lectures delivered by both Honorable Guests and Members of the Keynote Forum. The list includes:

  • Dr. Debby Laukens, Ghent University, Belgium
  • Dr. Larry I Good, Good Pharmaceutical Development Company, USA
  • Dr. Ahmed Zaki Helaly, Alexandria University, Egypt
  • Dr. Fratila Ovidiu, University of Oradea, Romania

Conference Series LLC  thank all the esxpert presenters and exuberant participants from all around the World which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

We would like to thank all of our wonderful Speakers, Conference Attendees, Students, Delegates and Guests for making Gastro-2015 a wonderful event!

 


Past Reports  Gallery  

Hepatitis 2015

Conference Series LLC takes a great pride in announcing the commencement of "World Congress on Hepatitis” during July 20-22, 2015 at Hyatt Regency Orlando International Airport, Florida, USA. The conference highlights the theme “Raising global awareness on hepatitis and fighting the stigma surrounding the disease”. It is the annual meeting for the study of Hepatitis.

With the support and contribution of the organizing committee members, we successfully hosted an event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals, Professors, Researchers, Experts and Students from diverse groups who made this conference as one of the most successful and productive event in 2015 from Conference Series LLC. The conference was marked with the attendance of young researchers, business delegates and students who have driven this event into the path of success.  

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. Mark A Feitelson, Associate Director, Temple University, USA. The proceedings went through interactive sessions and panel discussions headed by Dr. Trent W Nichols, AMRI, USA, an honorable Moderator for the conference, who contributed a major part for the success of this event. The event offers a best platform with its well organized scientific program to the audience on the topics Hepatitis Care and Cure, Diagnosis & Liver Pathology/ Case Studies, Assessment of Liver Diseases, Liver  cancer and Hepatocellular carcinoma, Advanced Management of Liver diseases, Clinical Liver Transplantation and Liver Surgery, Advancement in new drug discovery for treatment of hepatitis, Advance Technologies for the treatment of hepatitis and Liver diseases, Current research in Hepatology.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of hepatitis, carried out through various scientific-sessions and plenary lectures:

  • Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? -Dr. Mark A Feitelson, Temple University, USA
  • The Growing Epidemic in HCC from Hepatitis/NASH Cirrhosis in American Veterans-Dr. Trent W Nichols, AMRI, USA
  • Lower GI Bleeding in Patients with cirrhosis- Dr. Maxwell M Chait, Columbia University, USA
  • Impacts of platelets on the prognosis of patients with hepatocellular carcinoma– Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan

Also, the conference proceeding was encouraged through the wonderful symposiums by Dr. Andre Jean Remy, Perpignan Hospital, France, on the title ” New tools of screening viral hepatitis in real life: The French model of care and by Dr. Ehab Abd-El-Atty, Menoufia University, Egypt, on the title “HCC risk factors synergism in Egypt and how to prevent?”

A workshop session was done on “The Cirrhosis Micro-environment and Hepato-carcinogenesis” by Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan.

Conference Series LLC has taken the privilege of felicitating Hepatitis-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. OMICS International, on behalf of the conference exhibitor congratulate the Best Poster awardee for her outstanding performance in the field of Hepatocellular carcinoma and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. 

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series LLC Journal of Liver and Journal of Liver Disease and Transplantation as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals, Participants, Attendees, Sponsors, Exhibitors, and Media partners for their gracious presence and generous support, without which the conference would not have been possible. With the unique feedback from the conference, Conference Series LLC would like to announce the commencement of the "International Conference on Pancreatic Disorders and Treatment” May 12-14, 2016 in Chicago, USA.


Past Reports  Gallery  

Gastroenterology-2015

With the trail of success of our previous conferences, Conference Series LLC hosted the 4th International Conference on Gastroenterology (Gastroenterology-2015) during July 20-22, 2015 at Hyatt Regency Orlando, Florida. Generous response was received from the Editorial Board Members of Conference Series LLC Journals as well as from eminent scientists, talented researchers and young student community. The three day program witnessed thought provoking keynote and plenary presentations from experts in the field of Advances in Gastrointestinal Diseases, Gastrointestinal Oncology, Gastrointestinal Immunology, and Advances in Liver Diseases, Gastrointestinal Surgery and Pediatric Urology highlighting the theme “Current Advancements in Gastroenterology

Gastroenterology-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Maxwell M. Chait, Columbia University, USA and Dr. Abigail Basson, University of Western Cape, South Africa who contributed meticulously and exuberantly for the smooth functioning of this event.

Conference Series LLC would like to convey a warm gratitude to all the Honorable Guests and Keynote Speakers of Gastroenterology-2015:

  • Maxwell M. Chait, Columbia University, USA
  • Mary Es. Beaver, Texas Centre of Voice and Swallowing, USA
  • Abigail Basson, University of Western Cape, South Africa

All the above mentioned Honorable Guests, Keynote Speakers and other speakers gave their fervent and peerless contributions at Gastroenterology-2015. The conference proceedings were carried out through various Scientific-sessions and plenary lectures.

Conference Series LLC congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Pavel Vodicka, Institute of Experimental Medicine, Czech Republic for his valuable time.          

Conference Series LLC also took the privilege of felicitating Gastroenterology-2015, Chair and Co-Chairs whose paramount support escorted the conference to the pinnacle of success.

  • Mary Es. Beaver, Texas Centre of Voice and Swallowing, USA
  • Na Li, The Ohio State University, USA
  • Abigail Basson, University of Western Cape, South Africa
  • Joshua Ko, Hong Kong Baptist University, China
  • Nisreene Mahmoud, Cairo University, Egypt
  • Mrinal Pahwa, Sir Ganga Ram Hospital, India

We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gastroenterology research.


Past Reports  Proceedings  Gallery  

Gastroenterology-2014

The 3rd International Conference on Gastroenterology & Urology hosted by the Conference Series LLC was successfully held during July 28-30, 2014 in San Francisco, USA. The conference gathered scientists, researchers and leaders from Gastroenterology & Urology societies, government organizations, students who made this conference as one of the most successful event. 

The conference started on July 28 with an opening ceremony in which honorable guest presentations took place on the theme of this Conference "Accelerating New Research and Technologies in Gastroenterology and Urology". Based on this, speaker's discussions included many recommendations. 

Keynote Speakers:

  • Dr. Maxwell Chait, Columbia University College of Physicians and Surgeons, USA
  • Dr. Christos E Constantinou, Stanford University School of Medicine, USA
  • Dr. Amr Amin, UAE University, UAE

All above mentioned keynote speakers gave their energetic and fruitful contributions at 3rd International Conference on Gastroenterology & Urology.  The session chairs/Co chairs have proved their position and contributed a lot for the smooth functioning of the event.

All accepted abstracts have been indexed in the Conference Series LLC Journal of Gastrointestinal & Digestive system as a special issue. Conference Series LLC felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.

We wish to pioneer a way to another outstanding event in the UK.


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 11-12, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
gastro@omicsgroup.com
Sponsors / Exhibiting / Advertising.
gastro@conferenceseries.net
General Queries.
gastro@conferenceseries.com

View Proceedings of Previous Conferences

Gastro 2015
Gastroenterology-2014
Gastroenterology-2013
Gastroenterology-2012
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.